메뉴 건너뛰기




Volumn 66, Issue 2, 2006, Pages 440-441

Rosuvastatin as treatment for non alcoholic steatohepatitis (NASH) and highly active antiretroviral therapy (HAART)-dyslipidaemia: New treatment for global dangers [4]

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CYTOCHROME P450; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

EID: 28844465375     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2005.09.003     Document Type: Letter
Times cited : (6)

References (6)
  • 1
    • 0038645309 scopus 로고    scopus 로고
    • Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial
    • P.H. Jones, M.H. Davidson, E.A. Stein, H.E. Bays, J.M. McKenney, and E. Miller Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial Am J Cardiol 92 2 2003 152 160
    • (2003) Am J Cardiol , vol.92 , Issue.2 , pp. 152-160
    • Jones, P.H.1    Davidson, M.H.2    Stein, E.A.3    Bays, H.E.4    McKenney, J.M.5    Miller, E.6
  • 2
    • 11344293751 scopus 로고    scopus 로고
    • Cardiovascular risk and body-fat abnormalities in HIV-infected adults
    • S. Grinspoon, and A. Carr Cardiovascular risk and body-fat abnormalities in HIV-infected adults N Engl J Med 352 1 2005 48 62
    • (2005) N Engl J Med , vol.352 , Issue.1 , pp. 48-62
    • Grinspoon, S.1    Carr, A.2
  • 3
    • 21844434482 scopus 로고    scopus 로고
    • Rosuvastatin for the treatment of hyperlipidaemia in HIV-infected patients receiving protease inhibitors: A pilot study
    • L. Calza, V. Colangeli, R. Manfredi, G. Legnani, L. Tampellini, and D. Pocaterra Rosuvastatin for the treatment of hyperlipidaemia in HIV-infected patients receiving protease inhibitors: a pilot study AIDS 19 10 2005 1103 1105
    • (2005) AIDS , vol.19 , Issue.10 , pp. 1103-1105
    • Calza, L.1    Colangeli, V.2    Manfredi, R.3    Legnani, G.4    Tampellini, L.5    Pocaterra, D.6
  • 4
    • 0001843697 scopus 로고    scopus 로고
    • Non alcoholic fatty liver disease: The most common cause of abnormal liver enzymes in the US population
    • J.M. Clark, F.L. Brancati, and A.M.E. Diehl Non alcoholic fatty liver disease: the most common cause of abnormal liver enzymes in the US population Gastroenterology 120 Suppl. 2001 a-65 [Abstract]
    • (2001) Gastroenterology , vol.120 , Issue.SUPPL. , pp. 65
    • Clark, J.M.1    Brancati, F.L.2    Diehl, A.M.E.3
  • 5
    • 0037129380 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease
    • P. Angulo Nonalcoholic fatty liver disease N Engl J Med 346 16 2002 1221 1231
    • (2002) N Engl J Med , vol.346 , Issue.16 , pp. 1221-1231
    • Angulo, P.1
  • 6
    • 20544432480 scopus 로고    scopus 로고
    • The safety of rosuvastatin as used in common clinical practice: A postmarketing analysis
    • A.A. Alsheikh-Ali, M.S. Ambrose, J.T. Kuvin, and R.H. Karas The safety of rosuvastatin as used in common clinical practice: a postmarketing analysis Circulation 111 23 2005 3051 3057
    • (2005) Circulation , vol.111 , Issue.23 , pp. 3051-3057
    • Alsheikh-Ali, A.A.1    Ambrose, M.S.2    Kuvin, J.T.3    Karas, R.H.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.